Show simple item record

dc.contributor.authorKrasny, Len_US
dc.contributor.authorHuang, PHen_US
dc.date.accessioned2020-10-12T08:42:44Z
dc.date.issued2020-10-09en_US
dc.identifier.citationMolecular omics, 2020en_US
dc.identifier.issn2515-4184en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4135
dc.identifier.eissn2515-4184en_US
dc.identifier.doi10.1039/d0mo00072hen_US
dc.description.abstractData-independent acquisition mass spectrometry (DIA-MS) is a next generation proteomic methodology that generates permanent digital proteome maps offering highly reproducible retrospective analysis of cellular and tissue specimens. The adoption of this technology has ushered a new wave of oncology studies across a wide range of applications including its use in molecular classification, oncogenic pathway analysis, drug and biomarker discovery and unravelling mechanisms of therapy response and resistance. In this review, we provide an overview of the experimental workflows commonly used in DIA-MS, including its current strengths and limitations versus conventional data-dependent acquisition mass spectrometry (DDA-MS). We further summarise a number of key studies to illustrate the power of this technology when applied to different facets of oncology. Finally we offer a perspective of the latest innovations in DIA-MS technology and machine learning-based algorithms necessary for driving the development of high-throughput, in-depth and reproducible proteomic assays that are compatible with clinical diagnostic workflows, which will ultimately enable the delivery of precision cancer medicine to achieve optimal patient outcomes.en_US
dc.formatPrint-Electronicen_US
dc.languageengen_US
dc.language.isoengen_US
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_US
dc.titleData-independent acquisition mass spectrometry (DIA-MS) for proteomic applications in oncology.en_US
dc.typeJournal Article
rioxxterms.versionofrecord10.1039/d0mo00072hen_US
rioxxterms.licenseref.startdate2020-10-09en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfMolecular omicsen_US
pubs.notesNo embargoen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Molecular and Systems Oncology
pubs.publication-statusPublisheden_US
pubs.embargo.termsNo embargoen_US
icr.researchteamMolecular and Systems Oncologyen_US
dc.contributor.icrauthorHuang, Paulen_US
dc.contributor.icrauthorKrasny, Lukasen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/